US Broker Ratings

Arcellx, Inc. (ACLX) Stock Analysis: A Promising Biotech Play with Significant Upside Potential

For investors with a keen interest in the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents an intriguing opportunity. As a healthcare company specializing in innovative immunotherapies, Arcellx is making strides..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 20% Upside Potential in Biotech

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is making waves with its innovative approach to treating serious metabolic diseases. Headquartered in South San Francisco, California,..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 36.85% Potential Upside in Innovative RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. Based in San Diego, California, Avidity is focused on delivering antibody..

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking a Potential 45% Upside in Biotech

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors seeking opportunities in the dynamic biotechnology sector. With a robust pipeline of therapies targeting central nervous system (CNS) disorders,..

Elanco Animal Health (ELAN) Stock Analysis: Growth Potential and Market Dynamics

Elanco Animal Health Incorporated (NYSE: ELAN) stands at the crossroads of innovation and animal welfare. With a market capitalization of $9.82 billion, this healthcare sector player is making strides in..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 57% Potential Upside Amidst Healthcare Innovations

In the dynamic realm of healthcare, Lantheus Holdings, Inc. (NASDAQ: LNTH) emerges as a compelling player, particularly for investors seeking opportunities in the specialty and generic drug manufacturing sector. With..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 72.68% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pivotal player in the healthcare sector, particularly within the medical devices industry, is catching the eye of investors with a promising potential upside..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 6.84% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the ophthalmic industry, has long been a beacon for innovation in eye health. With a market capitalization of $5.08 billion, the..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing investor attention due to its promising drug pipeline and notable upside potential. With a focused approach..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Powerhouse with 17% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, specializing in the treatment of rare neuroendocrine diseases. With its lead product, IMCIVREE (setmelanotide), Rhythm is making..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Healthcare Tech Landscape with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York, is garnering attention in the healthcare sector with its innovative approach to health plans and technology solutions...

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 99.86% Upside in the Biotech Space

ADMA Biologics Inc. (NASDAQ: ADMA), a prominent player in the biotechnology sector, has been capturing investor attention with its promising market position and growth potential. The company is committed to..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 38% Upside Potential with Robust Analyst Support

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, has been attracting considerable attention from investors due to its significant growth potential and strong pipeline of pharmaceutical..

Prestige Consumer Healthcare (PBH) Stock Analysis: Unveiling a Potential 35% Upside for Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on over-the-counter (OTC) health and personal care products...

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Growth, Innovation, and a Strategic Pipeline Fueling Investor Interest

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has been making waves with its innovative RNA-targeted medicines. With a market capitalization of $11.15 billion and a..

Smith & Nephew (SNN) Stock Analysis: Exploring Growth Amidst a Solid 6.61% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a formidable player in the healthcare sector, specifically in the medical devices industry. Headquartered in Watford, United Kingdom, the company boasts..

Legend Biotech Corporation (LEGN) Investor Outlook: Unpacking a 140.9% Potential Upside Amidst a Robust Oncology Pipeline

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with a remarkable 140.9% potential upside, anchored by its innovative strides in the biotechnology sector. As a leading player in the..

Telix Pharmaceuticals Limited (TLX) Investor Outlook: Unveiling a 117.90% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology industry, has been making waves with its innovative approach to radiopharmaceuticals. With its market capitalization standing at $3.31 billion,..

Doximity, Inc. (DOCS) Stock Analysis: Understanding the 6.86% Potential Upside for Investors

Doximity, Inc. (DOCS), a leader in the health information services sector, has carved out a unique niche in the digital healthcare landscape. With a market capitalization of $12.29 billion, Doximity..

BrightSpring Health Services (BTSG) Stock Analysis: A 5.54% Upside Amid Robust Revenue Growth

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is capturing investor attention with its impressive revenue growth of 29.10% and a potential upside of 5.54% based on the average target price from..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds